National Institutes of Health-sponsored clinical islet transplantation consortium phase 3 trial: Manufacture of a complex cellular product at eight processing facilities.

Eight manufacturing facilities participating in the National Institutes of Health-sponsored Clinical Islet Transplantation (CIT) Consortium jointly developed and implemented a harmonized process for the manufacture of allogeneic purified human pancreatic islet (PHPI) product evaluated in a phase 3 t...

Full description

Bibliographic Details
Main Authors:	Ricordi, C, Goldstein, J, Balamurugan, A, Szot, G, Kin, T, Liu, C, Czarniecki, C, Barbaro, B, Bridges, N, Cano, J, Clarke, W, Eggerman, T, Hunsicker, L, Kaufman, D, Khan, A, Lafontant, D, Linetsky, E, Luo, X, Markmann, J, Naji, A, Korsgren, O, Oberholzer, J, Turgeon, N, Brandhorst, D, Chen, X, Friberg, A, Lei, J, Wang, L, Wilhelm, J, Willits, J, Zhang, X, Hering, B, Posselt, A, Stock, P, Shapiro, A
Format:	Journal article
Language:	English
Published:	American Diabetes Association 2016

National Institutes of Health-sponsored clinical islet transplantation consortium phase 3 trial: Manufacture of a complex cellular product at eight processing facilities.

Similar Items